Improving Peptide Receptor Radionuclide Therapy With PARP Inhibitors
Clinical trial NCT05870423 · RECRUITING
Trial details
- NCT number
- NCT05870423
- Sponsor
- Erasmus Medical Center
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-01
- Primary completion
- 2027-01-01
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.